<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Medicare Part D Opioid Prescribing Integrity Analytics</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: #ffffff;
            color: #2c3e50;
            line-height: 1.5;
            font-size: 11pt;
        }

        @page {
            size: A4;
            margin: 15mm 20mm;
        }

        @media print {
            .page {
                page-break-after: always;
                min-height: 297mm;
                max-height: 297mm;
                padding: 0;
                margin: 0;
            }
        }

        .page {
            max-width: 210mm;
            min-height: 297mm;
            margin: 0 auto;
            padding: 20mm;
            background: white;
        }

        .header {
            margin-bottom: 20px;
            border-bottom: 3px solid #003d7a;
            padding-bottom: 15px;
        }

        .header h1 {
            color: #003d7a;
            font-size: 24pt;
            font-weight: 700;
            margin-bottom: 5px;
            line-height: 1.2;
        }

        .subtitle {
            color: #666;
            font-size: 11pt;
            font-style: italic;
            line-height: 1.4;
        }

        .section-header {
            background: linear-gradient(135deg, #003d7a 0%, #0056b3 100%);
            color: white;
            padding: 8px 15px;
            font-size: 12pt;
            font-weight: 600;
            margin: 20px 0 15px 0;
            border-radius: 3px;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        .metrics-container {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 15px;
            margin: 20px 0;
        }

        .metric-box {
            background: #f8f9fa;
            border: 2px solid #003d7a;
            border-radius: 5px;
            padding: 12px;
            text-align: center;
        }

        .metric-value {
            font-size: 22pt;
            font-weight: 700;
            color: #003d7a;
            margin-bottom: 3px;
        }

        .metric-label {
            font-size: 9pt;
            color: #666;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 15px 0;
            font-size: 10pt;
        }

        th {
            background: #003d7a;
            color: white;
            padding: 8px 10px;
            text-align: left;
            font-weight: 600;
            font-size: 10pt;
        }

        td {
            padding: 8px 10px;
            border-bottom: 1px solid #ddd;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        .roadmap-table {
            margin-top: 15px;
        }

        .roadmap-table th {
            background: #0056b3;
        }

        .risk-table th {
            background: #dc3545;
        }

        .performance-table th {
            background: #28a745;
        }

        .specialty-list {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px;
            margin: 15px 0;
            font-size: 10pt;
        }

        .specialty-item {
            background: #fff3cd;
            border-left: 4px solid #ffc107;
            padding: 8px 12px;
        }

        .feature-list {
            margin: 15px 0;
        }

        .feature-item {
            display: flex;
            justify-content: space-between;
            padding: 8px 12px;
            margin: 5px 0;
            background: #e7f3ff;
            border-left: 4px solid #0056b3;
            font-size: 10pt;
        }

        .feature-name {
            font-weight: 600;
            color: #003d7a;
        }

        .feature-importance {
            color: #666;
            font-weight: 500;
        }

        .kpi-container {
            display: grid;
            grid-template-columns: repeat(5, 1fr);
            gap: 10px;
            margin: 20px 0;
        }

        .kpi-box {
            background: linear-gradient(135deg, #e7f3ff 0%, #fff 100%);
            border: 1px solid #0056b3;
            border-radius: 5px;
            padding: 10px;
            text-align: center;
        }

        .kpi-value {
            font-size: 18pt;
            font-weight: 700;
            color: #003d7a;
            margin-bottom: 2px;
        }

        .kpi-label {
            font-size: 8pt;
            color: #666;
            text-transform: uppercase;
        }

        .validation-grid {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 15px;
            margin: 20px 0;
        }

        .validation-box {
            background: #f0f8ff;
            border: 2px solid #0056b3;
            border-radius: 5px;
            padding: 15px;
        }

        .validation-title {
            font-weight: 700;
            color: #003d7a;
            margin-bottom: 10px;
            font-size: 11pt;
        }

        .validation-content {
            font-size: 10pt;
            color: #333;
            line-height: 1.5;
        }

        .impact-section {
            background: linear-gradient(135deg, #003d7a 0%, #0056b3 100%);
            color: white;
            padding: 20px;
            border-radius: 5px;
            margin-top: 25px;
            text-align: center;
        }

        .impact-title {
            font-size: 12pt;
            font-weight: 600;
            margin-bottom: 10px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .impact-value {
            font-size: 28pt;
            font-weight: 700;
            margin-bottom: 10px;
        }

        .impact-description {
            font-size: 10pt;
            opacity: 0.95;
            line-height: 1.5;
        }
    </style>
</head>
<body>
    <!-- PAGE 1: PROJECT OVERVIEW & ANALYSIS -->
    <div class="page">
        <div class="header">
            <h1>Medicare Part D Opioid Prescribing Integrity Analytics</h1>
            <p class="subtitle">Data-driven analytical framework identifying high-risk opioid prescribing patterns within Medicare Part D through machine learning and peer benchmarking to enhance patient safety and fiscal integrity</p>
        </div>
        
        <div class="section-header">THE OPIOID PRESCRIBING CRISIS</div>
        <div class="metrics-container">
            <div class="metric-box">
                <div class="metric-value">$128.2B</div>
                <div class="metric-label">Medicare Part D Payments to Plans (2023)</div>
            </div>
            <div class="metric-box">
                <div class="metric-value">$3.58B</div>
                <div class="metric-label">Annual Improper Payments (3.70% Rate)</div>
            </div>
            <div class="metric-box">
                <div class="metric-value">51,660</div>
                <div class="metric-label">High-Risk Prescribers Identified</div>
            </div>
            <div class="metric-box">
                <div class="metric-value">$1.22B</div>
                <div class="metric-label">Annual Excess Costs Identified</div>
            </div>
        </div>
        
        <div class="section-header">IMPLEMENTATION ROADMAP</div>
        <table class="roadmap-table">
            <thead>
                <tr>
                    <th>Phase</th>
                    <th>Timeline</th>
                    <th>Scope</th>
                    <th>Investment</th>
                    <th>Projected Recovery</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td><strong>Phase I</strong></td>
                    <td>Years 1-2</td>
                    <td>Top 100-500 prescribers pilot</td>
                    <td>$3-5M annually</td>
                    <td>$5-10M (Y1), $25-50M (Y2)</td>
                </tr>
                <tr>
                    <td><strong>Phase II</strong></td>
                    <td>Years 3-4</td>
                    <td>All 51,660 high-risk prescribers</td>
                    <td>$10-15M annually</td>
                    <td>$60-120M (Y3), $122-244M (Y4)</td>
                </tr>
                <tr>
                    <td><strong>Phase III</strong></td>
                    <td>Years 5+</td>
                    <td>Multi-payer exploration</td>
                    <td>$20-30M</td>
                    <td>$300-500M across all programs</td>
                </tr>
            </tbody>
        </table>
        
        <div class="section-header">GEOGRAPHIC DISTRIBUTION OF EXCESS COSTS</div>
        <table class="risk-table">
            <thead>
                <tr>
                    <th>State</th>
                    <th>Identified Excess Cost</th>
                    <th>Anomaly Rate</th>
                    <th>Regional Pattern</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Florida</td>
                    <td>$101.8 million</td>
                    <td>Above National Average</td>
                    <td>Highest concentration</td>
                </tr>
                <tr>
                    <td>California</td>
                    <td>$80.2 million</td>
                    <td>Above National Average</td>
                    <td>Second highest</td>
                </tr>
                <tr>
                    <td>Texas</td>
                    <td>$69.7 million</td>
                    <td>Above National Average</td>
                    <td>Third highest</td>
                </tr>
                <tr>
                    <td>Southern States</td>
                    <td>Concentrated excess</td>
                    <td>6.2% (vs 4.1% national)</td>
                    <td>Systematic elevation</td>
                </tr>
            </tbody>
        </table>
        
        <div class="section-header">HIGH-RISK SPECIALTY PATTERNS</div>
        <div class="specialty-list">
            <div class="specialty-item">Pain Management Specialists</div>
            <div class="specialty-item">General Practitioners (outliers)</div>
            <div class="specialty-item">Internal Medicine (high-volume)</div>
            <div class="specialty-item">Family Practice (rural variations)</div>
        </div>
        
        <div class="section-header">TOP 5 RISK INDICATORS</div>
        <div class="feature-list">
            <div class="feature-item">
                <span class="feature-name">Peer Deviation Score</span>
                <span class="feature-importance">34% importance</span>
            </div>
            <div class="feature-item">
                <span class="feature-name">Total Claims Volume</span>
                <span class="feature-importance">24% importance</span>
            </div>
            <div class="feature-item">
                <span class="feature-name">Prescribing Rate</span>
                <span class="feature-importance">18% importance</span>
            </div>
            <div class="feature-item">
                <span class="feature-name">Intensity Ratio</span>
                <span class="feature-importance">14% importance</span>
            </div>
            <div class="feature-item">
                <span class="feature-name">Cost Metrics</span>
                <span class="feature-importance">10% importance</span>
            </div>
        </div>
    </div>
    
    <!-- PAGE 2: MODEL VALIDATION & RESULTS -->
    <div class="page">
        <div class="header">
            <h1>MODEL VALIDATION & PERFORMANCE RESULTS</h1>
            <p class="subtitle">Triple validation framework demonstrating strong predictive accuracy, measurable return on investment, and real-world confirmation of system effectiveness</p>
        </div>
        
        <div class="section-header">KEY PERFORMANCE INDICATORS</div>
        <div class="kpi-container">
            <div class="kpi-box">
                <div class="kpi-value">61.6%</div>
                <div class="kpi-label">Method Concordance</div>
            </div>
            <div class="kpi-box">
                <div class="kpi-value">63%</div>
                <div class="kpi-label">2-Year Persistence</div>
            </div>
            <div class="kpi-box">
                <div class="kpi-value">5.0%</div>
                <div class="kpi-label">Detection Rate</div>
            </div>
            <div class="kpi-box">
                <div class="kpi-value">2.3%</div>
                <div class="kpi-label">Bootstrap Error</div>
            </div>
            <div class="kpi-box">
                <div class="kpi-value">45:1</div>
                <div class="kpi-label">Max ROI Potential</div>
            </div>
        </div>
        
        <div class="section-header">VALIDATION METRICS</div>
        <div class="validation-grid">
            <div class="validation-box">
                <div class="validation-title">Statistical Validation</div>
                <div class="validation-content">
                    • 61.6% concordance between ML and statistical methods<br>
                    • Bootstrap validation: 100 iterations<br>
                    • 95% confidence interval: $1.21-1.24 billion<br>
                    • Standard error: 2.3% for anomaly counts
                </div>
            </div>
            <div class="validation-box">
                <div class="validation-title">External Validation</div>
                <div class="validation-content">
                    • Matches with OIG enforcement actions<br>
                    • Alignment with CMS audit standards<br>
                    • Consistent with GAO recommendations<br>
                    • 3,234 OIG exclusions referenced (FY 2024)
                </div>
            </div>
        </div>
        
        <div class="section-header">MODEL COMPARISON RESULTS</div>
        <table class="performance-table">
            <thead>
                <tr>
                    <th>Method</th>
                    <th>Flagged Prescribers</th>
                    <th>Concordance</th>
                    <th>Processing Time</th>
                    <th>Validation Status</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Isolation Forest ML</td>
                    <td>51,660 (5.0%)</td>
                    <td>Primary method</td>
                    <td>47.3 seconds</td>
                    <td>Validated</td>
                </tr>
                <tr>
                    <td>Statistical Z-score</td>
                    <td>443,988 (at 3 SD)</td>
                    <td>61.6% agreement</td>
                    <td>Comparable</td>
                    <td>Baseline comparison</td>
                </tr>
                <tr>
                    <td>Current OIG Methods</td>
                    <td>1,714 (of 742,000)</td>
                    <td>Limited coverage</td>
                    <td>Manual review</td>
                    <td>Existing approach</td>
                </tr>
            </tbody>
        </table>
        
        <div class="section-header">FINANCIAL IMPACT PROJECTIONS</div>
        <table class="risk-table">
            <thead>
                <tr>
                    <th>Scenario</th>
                    <th>Identified Excess</th>
                    <th>Recovery Rate</th>
                    <th>Annual Recovery</th>
                    <th>ROI</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Conservative (10%)</td>
                    <td>$1.22 billion</td>
                    <td>10%</td>
                    <td>$122 million</td>
                    <td>12:1</td>
                </tr>
                <tr>
                    <td>Moderate (15%)</td>
                    <td>$1.22 billion</td>
                    <td>15%</td>
                    <td>$183 million</td>
                    <td>28:1</td>
                </tr>
                <tr>
                    <td>Optimistic (20%)</td>
                    <td>$1.22 billion</td>
                    <td>20%</td>
                    <td>$244 million</td>
                    <td>45:1</td>
                </tr>
                <tr>
                    <td>10-Year Cumulative</td>
                    <td>$12.2 billion</td>
                    <td>10-20%</td>
                    <td>$1.2-2.4 billion</td>
                    <td>Sustained</td>
                </tr>
            </tbody>
        </table>
        
        <div class="section-header">SYSTEM SPECIFICATIONS</div>
        <div class="validation-grid">
            <div class="validation-box">
                <div class="validation-title">Technical Details</div>
                <div class="validation-content">
                    • 1.38 million prescribers processed<br>
                    • 1.03 million after cleaning & exclusions<br>
                    • 2,020 peer groups established<br>
                    • 7,701 clinical exclusions applied<br>
                    • Processing time: 47.3 seconds total
                </div>
            </div>
            <div class="validation-box">
                <div class="validation-title">Data Sources</div>
                <div class="validation-content">
                    • CMS Part D Prescriber PUF (2023)<br>
                    • OIG List of Excluded Individuals/Entities<br>
                    • CDC National Vital Statistics System<br>
                    • Medicare Part D Drug Spending Dashboard<br>
                    • Medicare Part D Opioid Prescribing Rates
                </div>
            </div>
        </div>
        
        <div class="impact-section">
            <div class="impact-title">PROJECTED NATIONAL IMPACT</div>
            <div class="impact-value">$122M - $244M</div>
            <p class="impact-description">Annual recoverable savings based on conservative 10-20% historical recovery rates from $1.22 billion in identified excess Medicare Part D costs. Implementation provides systematic detection of 51,660 high-risk prescribers, advancing federal mandates under the SUPPORT Act while protecting Medicare beneficiaries through data-driven program integrity.</p>
        </div>
    </div>
</body>
</html>
